If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
800.50    5.50 (0.69%)
Bid:
801.00
Ask:
801.50
Spread: 0.50 (0.062%)
Market Cap: £1.61b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Result of EGM

18 Mar 2010 09:45

RNS Number : 7834I
Dunelm Group plc
18 March 2010
 

ïŧŋ

 

 

18 March 2010

 

 

DUNELM GROUP plc

 

RESULTS OF GENERAL MEETING

PROPOSED RETURN OF CAPITAL

 

Dunelm Group plc (the "Company") is pleased to announce that the resolution proposed at the General Meeting of the Company held at 9.00 a.m. today was duly passed as a special resolution. Accordingly the proposed return of capital of 21.5 pence per Ordinary Share by way of a "B" share scheme, as set out in a circular to shareholders posted on 25 February 2010 (the "Circular"), will proceed.

 

The proxy votes in respect of the resolution were:

 

For / discretionary

177,446,167

99.99 %

Against

0

0 %

Withheld

4,500

0.01%

 

The expected timetable of future events is:

 

Ordinary Share Record Date for participation in the Return of Capital

6.00 pm 18 March 2010

Latest time for receipt of Election Forms from certificated Shareholders and TTE Instructions from CREST holders in relation to the B Share Alternatives

4.30 pm 25 March 2010

Initial B Share Redemption and Single B Share Dividend Date

26 March 2010

Final B Share Redemption Date

24 June 2010

All times referred to are London times unless otherwise stated.

 

A copy of the resolution passed at the meeting has been submitted to the UK Listing Authority, and will shortly be available for inspection at the Document Viewing Facility, which is situated at:

 

Financial Services Authority

25 The North Colonnade

Canary Wharf

London E14 5HS

Tel: (0)20 7066 1000

 

 

 

Notes

1. Terms used but not defined in this announcement have the meanings given to them in the Circular sent by Dunelm Group plc to its shareholders dated 25 February 2010.

2. This announcement does not constitute an offer or form part of any offer or invitation to purchase, subscribe for, sell or issue, or a solicitation of any offer to purchase, subscribe for, sell or issue Dunelm Group Ordinary Shares, B Shares or any other securities in Dunelm Group plc. This announcement does not constitute a prospectus equivalent document.

3. Overseas Shareholders may be affected by the laws of other jurisdictions in relation to the Proposals or the distribution of this announcement. Persons into whose possession this announcement comes should inform themselves about and observe any applicable restrictions and legal, exchange control or regulatory requirements in relation to the Return of Capital, the distribution of this announcement and the Circular. Any failure to comply with such restrictions or requirements may constitute a violation of the securities laws of any such jurisdiction. This announcement is not an offer of securities for sale in the United States. 

4. Please note that all entitlements will be rounded down to the nearest penny.

 

 

For further information please contact:

 

Dunelm Group plc

0116 2644 356

Will Adderley, Chief Executive

David Stead, Finance Director

Hogarth Partnership

020 7357 9477

John Olsen

Simon Hockridge

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGEANDPFLFEEEF
Date   Source Headline
1st Jul 20267:00 amRNSTotal Voting Rights
11th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20267:00 amRNSTotal Voting Rights
12th May 20267:00 amRNSDirector/PDMR Shareholding
8th May 20263:27 pmRNSDirector/PDMR Shareholding - Replacement
8th May 202611:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSThird quarter trading update
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20263:24 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSPurchases of Shares During Open Periods
13th Feb 202611:00 amRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSInterim Results
2nd Feb 20267:00 amRNSTotal Voting Rights
15th Jan 20267:00 amRNSSecond quarter and first half trading update
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
9th Dec 20257:00 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSPDMR Shareholding
28th Nov 20257:00 amRNSTotal Voting Rights
25th Nov 202510:14 amRNSDirector/PDMR Shareholding Amendment
25th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20252:30 pmRNSResult of AGM
11th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
31st Oct 20259:52 amRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFirst quarter trading statement
9th Oct 202510:00 amRNSNotice of AGM, Annual Report and Accounts
8th Oct 20257:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.